Arnon P. Kater

Research output

Research output per year 1999 2016 2019 2020 2021 2022 2023 2024

• 169 Article
• 25 Comment/Letter to the editor
• 25 Review article
• 10 Editorial
• 8 More
  • 5 Letter
  • 1 Chapter
  • 1 Phd-Thesis - Research and graduation internal
  • 1 Preprint

Research output per year

Research output per year

Search results

• 2024

  Epcoritamab, a Promising Therapy for Richter Syndrome?

  Kater, A., 1 Mar 2024, In: Clinical advances in hematology & oncology. 22, 2, p. 90-91 2 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

• The GLOW trial in chronic lymphocytic leukaemia – Authors' reply

  Niemann, C. U. & Kater, A. P., 1 Feb 2024, In: The Lancet Oncology. 25, 2, p. e56

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
• 2023

  Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia

  Hengeveld, P. J., Schilperoord-Vermeulen, J., van der Klift, M. Y., Dubois, J. M. N., Kolijn, P. M., Kavelaars, F. G., Rijken, M., Dobber, J. A., Nasserinejad, K., Kersting, S., Westerweel, P. E., Kater, A. P., Langerak, A. W. & Levin, M. D., 1 Dec 2023, In: Blood Cancer Journal. 13, 1, 102.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis

  Hengeveld, P. J., Veelken, H., van Bergen, C. A. M., Quinten, E., Vervoordeldonk, M. Y. L., Ismailzada, W., Barendse, R. S., Dubois, J. M. N., van Oers, M. H. J., Geisler, C. H., Kater, A. P., Westerweel, P. E., Langerak, A. W. & Levin, M-D., Sept 2023, In: Leukemia. 37, 9, p. 1929-1932 4 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
• 2022

  Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989–2018

  van der Straten, L., Maas, C. C. H. M., Levin, M-D., Visser, O., Posthuma, E. F. M., Doorduijn, J. K., Langerak, A. W., Kater, A. P. & Dinmohamed, A. G., 1 Apr 2022, In: Blood Cancer Journal. 12, 4, 72.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  5 Citations (Scopus)

• Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

  Thompson, M. C., Harrup, R. A., Coombs, C. C., Roeker, L. E., Pu, J. J., Choi, M. Y., Barr, P. M., Allan, J. N., Simkovi, M., Leslie, L., Rhodes, J., Chong, E. A., Kamdar, M., Skarbnik, A., Lansigan, F., McCall, B., Saja, K., Dyer, M. J. S., Walter, H. S., Lefebure, M., & 18 othersThadani-Mulero, M., Boyer, M., Biondo, J., Sail, K., Manzoor, B. S., Furman, R., Bantilan, K. S., Goy, A., Feldman, T., Labella, D., Schuster, S. J., Park, J., Palomba, L., Zelenetz, A., Eyre, T. A., Kater, A. P., Seymour, J. F. & Mato, A. R., 9 Aug 2022, In: Blood advances. 6, 15, p. 4553-4557 5 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  23 Citations (Scopus)
• 2021

  Correction: Van bruggen et al. Overcoming the hurdles of autologous T-cell-based therapies in B-cell non-hodgkin lymphoma (Cancers (2020), 12, (3837), 10.3390/cancers12123837)

  van Bruggen, J. A. C., Martens, A. W. J., Tonino, S. H. & Kater, A. P., 1 Oct 2021, In: Cancers. 13, 19, 4738.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia

  Niemann, C. U., Levin, M-D., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Mattsson, M., Bellido, M., Tran, H. T. T., Nasserinejad, K. & Kater, A. P., 25 Feb 2021, In: Blood. 137, 8, p. 1117-1120 4 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  22 Citations (Scopus)
• 2020

  Response in patients with BIRC3-mutated relapsed/refractory chronic lymphocytic leukemia treated with fixed-duration venetoclax and rituximab

  Kater, A. P., Jiang, Y., Chyla, B. & Seymour, J. F., 1 Jul 2020, In: Haematologica. 105, 7, p. e382-e383

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  6 Citations (Scopus)
• 2019

  Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma

  Wang, M., Rule, S., Zinzani, P. L., Goy, A., Casasnovas, O., Smith, S. D., Damaj, G., Doorduijn, J. K., Lamy, T., Morschhauser, F., Panizo, C., Shah, B., Davies, A., Eek, R., Dupuis, J., Jacobsen, E., Kater, A. P., le Gouill, S., Oberic, L., Robak, T., & 7 othersJain, P., Frigault, M. M., Izumi, R., Nguyen, D., Patel, P., Yin, M. & Długosz-Danecka, M., Nov 2019, In: Leukemia. 33, 11, p. 2762-2766

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  71 Citations (Scopus)
• 2018

  Authors reply: Venetoclax-Rituximab in Chronic Lymphocytic Leukemia

  Seymour, J. F., Mobasher, M. & Kater, A. P., 2018, In: New England journal of medicine. 378, 22, p. 2143-2144 2 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  3 Citations (Scopus)

• Final results of a phase 1b study of the safety and efficacy of the PI3Kδ inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies

  Kater, A. P., Tonino, S. H., Spiering, M., Chamuleau, M. E. D., Liu, R., Adewoye, A. H., Gao, J., Dreiling, L., Xin, Y., Doorduijn, J. K. & Kersten, M. J., 2018, In: Blood Cancer Journal. 8, 2, p. 16 16.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  19 Citations (Scopus)
• 2017

  Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection

  van der Valk, M., Zaaijer, H. L., Kater, A. P. & Schinkel, J., 2017, In: Journal of Hepatology. 66, 1, p. 242-243

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  61 Citations (Scopus)
• 2016

  Chronic lymphocytic leukemia development is accelerated in mice with deficiency of the pro-apoptotic regulator NOXA

  Slinger, E., Wensveen, F. M., Guikema, J. E., Kater, A. P. & Eldering, E., 2016, In: Haematologica. 101, 9, p. e374-e377

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  6 Citations (Scopus)

• Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia

  de Weerdt, I., van Hoeven, V., Munneke, J. M., Endstra, S., Hofland, T., Hazenberg, M. D. & Kater, A. P., 2016, In: Haematologica. 101, 11, p. e461-e464

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  41 Citations (Scopus)

• The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 ( voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells (Vol 30, pg 337, 2016)

  Thijssen, R., ter Burg, J., van Bochove, G. G. W., de Rooij, M. F. M., Kuil, A., Jansen, M. H., Kuijpers, T. W., Baars, J. W., Virone-Oddos, A., Spaargaren, M., Egile, C., van Oers, M. H. J., Eldering, E., Kersten, M. J. & Kater, A. P., 2016, In: Leukemia. 30, 9, p. 1963

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
• 2015

  Ibrutinib and idelalisib synergistically target BCR-controlled adhesion in MCL and CLL: a rationale for combination therapy

  de Rooij, M. F. M., Kuil, A., Kater, A. P., Kersten, M. J., Pals, S. T. & Spaargaren, M., 2015, In: Blood. 125, 14, p. 2306-2309

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  80 Citations (Scopus)

• Resistance to ABT-199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors

  Thijssen, R., Slinger, E., Weller, K., Geest, C. R., Beaumont, T., van Oers, M. H. J., Kater, A. P. & Eldering, E., 2015, In: Haematologica. 100, 8, p. e302-e306

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  107 Citations (Scopus)
• 2014

  Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approach

  te Raa, G. D., Malčiková, J., Mraz, M., Trbusek, M., Le Garff-Tavernier, M., Merle-Béral, H., Greil, R., Merkel, O., Pospíšilová, S., Lin, K., Pettitt, A. R., Stankovic, T., van Oers, M. H., Eldering, E., Stilgenbauer, S., Zenz, T. & Kater, A. P., 2014, In: British journal of haematology. 167, 4, p. 565-569

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  8 Citations (Scopus)
• 2011

  Waxing and waning intravascular large cell lymphoma with widespread organ infiltration

  Vos, J. M. I., Bordbar, A., Vet, R., Pals, S. T. & Kater, A. P., 2011, In: Leukemia & lymphoma. 52, 4, p. 705-708

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  1 Citation (Scopus)
• 2010

  Chronic lymphocytic leukemia of Eμ-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression (Blood (2009) 114, 20 (4469-4476))

  Enzler, T., Kater, A. P. & Zhang, W., 29 Jul 2010, In: Blood. 116, 4, p. 671 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

• R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia

  Tonino, S. H., van Gelder, M., Eldering, E., van Oers, M. H. & Kater, A. P., 2010, In: Leukemia. 24, 3, p. 652-654

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  15 Citations (Scopus)
• 2009

  Detection of p53 dysfunction in chronic lymphocytic leukaemia cells through multiplex quantification of p53 target gene induction

  Mous, R., Jaspers, A., Luijks, D. M. P., Mellink, C. H. M., van Oers, M. H. J., Kater, A. P. & Eldering, E., 2009, In: Leukemia. 23, 7, p. 1352-1355

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  12 Citations (Scopus)
• 2008

  Invasive infections with a coagulase-negative staphylococcus in an immunocompromised patient: case report and review of the literature

  Choi, G., van den Borne, M. P. J., Visser, C. E., Kersten, M. J. & Kater, A. P., 2008, In: Annals of Hematology. 87, 9, p. 771-772

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  8 Citations (Scopus)
• 1999

  Transient thrombocytopenia after cardiac surgery in infants with Down syndrome

  Kater, A. P., Prins, M. H., von Rosenstiel, I. A., Ottenkamp, J. & Peters, M., 1999, In: Journal of pediatric hematology/oncology. 21, 2, p. 170-171

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  2 Citations (Scopus)